1. Nicotinamide N-Methyltransferase Is a Prognostic Biomarker and Correlated With Immune Infiltrates in Gastric Cancer
   Miaowei Wu et al, 2020, Frontiers in Genetics CrossRef
2. Nicotinamide N-Methyltransferase: A Promising Biomarker and Target for Human Cancer Therapy
   Xiao-Yu Li et al, 2022, Frontiers in Oncology CrossRef
3. Beyond Nicotinamide Metabolism: Potential Role of Nicotinamide N-Methyltransferase as a Biomarker in Skin Cancers
   Roberto Campagna et al, 2021, Cancers CrossRef
4. NNMT Is an Immune-Related Prognostic Biomarker That Modulates the Tumor Microenvironment in Pan-Cancer
   Wenxiu Liu et al, 2023, Disease Markers CrossRef
5. Proteomic Changes in the Monolayer and Spheroid Melanoma Cell Models of Acquired Resistance to BRAF and MEK1/2 Inhibitors
   Ramon Martinez et al, 2022, ACS Omega CrossRef
6. Decoding the Immune Microenvironment of Clear Cell Renal Cell Carcinoma by Single-Cell Profiling to Aid Immunotherapy
   Jie Liu et al, 2022, Frontiers in Immunology CrossRef
7. A tEMTing target? Clinical and experimental evidence for epithelial-mesenchymal transition in the progression of cutaneous squamous cell carcinoma (a scoping systematic review)
   Benjamin Genenger et al, 2022, Discover Oncology CrossRef
8. The Utility of Nicotinamide N-Methyltransferase as a Potential Biomarker to Predict the Oncological Outcomes for Urological Cancers: An Update
   Roberto Campagna et al, 2021, Biomolecules CrossRef
9. Investigating Cutaneous Squamous Cell Carcinoma in vitro and in vivo: Novel 3D Tools and Animal Models
   Marika Quadri et al, 2022, Frontiers in Medicine CrossRef
10. Methylosystem for Cancer Sieging Strategy
    Shotaro Tatekawa et al, 2021, Cancers CrossRef
11. Apprising Diagnostic and Prognostic Biomarkers in Cutaneous Melanoma—Persistent Updating
    Simona Roxana Georgescu et al, 2022, Journal of Personalized Medicine CrossRef